Loading clinical trials...

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT01718938

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

This is a multicenter, randomized, double-blind, incomplete block, three period fixed sequence crossover, multicenter, placebo-controlled study. The study will assess three oral doses of velusetrag (5...

Lead sponsor: Theravance Biopharma•9 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGEARLY Phase 1

Growth Hormone for the Treatment of Gastroparesis

NCT06803589 · Gastroparesis

RECRUITING

Study of Gastric Motility in Eosinophilic Gastritis

NCT05229432 · Eosinophilic Gastritis, Gastroparesis, and more

RECRUITING

Gastroparesis Outcome Longitudinal Database Enrolled Numerically

NCT03876288 · Gastroparesis

RECRUITINGNA

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

NCT07287943 · Type 1 Diabetes, Gastroparesis Due to Diabetes Mellitus Type I

RECRUITING

Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis

NCT07324785 · Diabetic Gastroparesis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 26, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment34

Start dateDec 2012

Last updatedFeb 26, 2018

Condition

Gastroparesis

Locations shown

Desert Sun Clinical Research

Tucson, Arizona

Axis Clinical Trials

Los Angeles, California

Ventura Clinical Trials

Ventura, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 26, 2018Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Growth Hormone for the Treatment of Gastroparesis

Study of Gastric Motility in Eosinophilic Gastritis

Gastroparesis Outcome Longitudinal Database Enrolled Numerically

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis

Trial snapshot

Condition

Locations shown

For caregivers